Recombinant Human LAIR1 protein (rFc Tag)
Species
Human
Purity
>90 %, SDS-PAGE
Tag
rFc Tag
Activity
not tested
Cat no : Eg2329
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Human LAIR1 protein Gln22-His163 (Accession# Q6GTX8-1) with a rabbit IgG Fc tag at the C-terminus. |
GeneID | 3903 |
Accession | Q6GTX8-1 |
PredictedSize | 41.8 kDa |
SDS-PAGE | 45-60 kDa, reducing (R) conditions |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
Leukocyte-associated immunoglobulin-like receptor 1 (LAIR1) is a transmembrane glycoprotein with a single immunoglobulin-like domain and a cytoplasmic tail containing two immune receptor tyrosine-based inhibitory motifs. LAIR1 is expressed on the majority of human PBMCs, including NK, T, B, monocytes, and dendritic cells, as well as the majority of thymocytes. It functions as an inhibitory receptor that plays a constitutive negative regulatory role on cytolytic function of NK cells, B cells and T cells. LAIR1 is a collagen receptor. Tumor-expressed collagens can modulate immune cell function through the inhibitory collagen receptor LAIR1.
References:
1. Meyaard L. et al. (1997) Immunity. 7(2):283-290. 2. Meyaard L. et al. (1999) J Immunol. 162(10):5800-5804. 3. Lebbink RJ. et al. (2006) J Exp Med. 203(6):1419-1425. 4, Rygiel TP. et al. (2011) Mol Immunol. 49(1-2):402-406.